Topics

How law can help solve the collective action problem of antimicrobial resistance.

08:00 EDT 3rd July 2019 | BioPortfolio

Summary of "How law can help solve the collective action problem of antimicrobial resistance."

Antimicrobial resistance is a global collective action problem with dire consequences for human health. This article considers how domestic and international legal mechanisms can be used to address antimicrobial resistance and overcome the governance and political economy challenges that accelerate it.

Affiliation

Journal Details

This article was published in the following journal.

Name: Bioethics
ISSN: 1467-8519
Pages:

Links

DeepDyve research library

PubMed Articles [13273 Associated PubMed Articles listed on BioPortfolio]

Collective action problems in offensive and defensive warfare.

A collective action problem exists not only in offensive warfare, but also in defensive situations. The collective action problem is dealt with in the same way in offensive and defensive warfare: by s...

Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE and Escherichia coli pathogens.

The aim of the study was to evaluate a cumulative antimicrobial resistance index (ARI) as a possible key outcome measure of antimicrobial stewardship (AS) programs and as a tool to predict antimicrobi...

Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies.

Overutilization of antimicrobials is a known contributor to the development of antimicrobial resistance, which is a threat to global health. The goal of antimicrobial stewardship programs (ASPs) is to...

Current status of countermeasures for infectious diseases and resistant microbes in the field of urology.

A worldwide increase in antimicrobial-resistant microbes due to the improper use of antimicrobial agents, along with a lack of progress in developing new antimicrobials, is becoming a societal problem...

Veterinary Anti-Microbial Resistance Containment in Bangladesh: evaluating the National Action Plan and scoping the evidence on implementation.

In 2015, the World Health Organization released the Global Action Plan on Anti-Microbial Resistance (GAP) as a blueprint for the design of National Action Plans for Anti-Microbial Resistance containme...

Clinical Trials [5763 Associated Clinical Trials listed on BioPortfolio]

Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

This is a four-year study, funded by the Center for Disease Control and Prevention, related to antimicrobial resistance in rural communities. The project consists of four components: A) ...

Impact of Antimicrobial Stewardship Programs in the Global Setting

Antimicrobial resistance is one of the greatest threats to human health, and is driven by inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of anti...

Intestinal Microbiota and Antimicrobial Resistance

Antimicrobial resistance is regarded as one of the major global public health threats, causing at least 700,000 deaths per year. It has been estimated that if the current problem of antimi...

Improving Antimicrobial-Prescribing in Emergency Departments

Antimicrobial resistance is one of today's most urgent public health problems. One of the most important strategies to slow the spread of antimicrobial resistance is the promotion of judic...

Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics

The study objective is to improve the current and local standard antiseptic treatment by adjusting the antiseptic agent to the antimicrobial resistance testing result, accordingly. Current...

Medical and Biotech [MESH] Definitions

The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.

Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Instructional use of examples or cases to teach using problem-solving skills and critical thinking.

Quick Search


DeepDyve research library

Searches Linking to this Article